These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 29912247)

  • 1. [The challenge in colistin dosing: Updating available recommendations].
    Rosales R; Rojas L; Zamora F; Izquierdo G; Benavides C; González C
    Rev Chilena Infectol; 2018 Apr; 35(2):105-116. PubMed ID: 29912247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colistin: understanding and applying recent pharmacokinetic advances.
    Ortwine JK; Kaye KS; Li J; Pogue JM
    Pharmacotherapy; 2015 Jan; 35(1):11-6. PubMed ID: 25187500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Product information for parenteral colistin varies substantially across Europe.
    Theuretzbacher U
    J Antimicrob Chemother; 2014 Jul; 69(7):1987-92. PubMed ID: 24633204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in pharmacokinetics and pharmacodynamics of colistimethate sodium (CMS) and colistin between three different CMS dosage regimens in a critically ill patient infected by a multidrug-resistant Acinetobacter baumannii.
    Luque S; Grau S; Valle M; Sorlí L; Horcajada JP; Segura C; Alvarez-Lerma F
    Int J Antimicrob Agents; 2013 Aug; 42(2):178-81. PubMed ID: 23769664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population Pharmacokinetics of Intravenous Colistin in Pediatric Patients: Implications for the Selection of Dosage Regimens.
    Ooi MH; Ngu SJ; Chor YK; Li J; Landersdorfer CB; Nation RL
    Clin Infect Dis; 2019 Nov; 69(11):1962-1968. PubMed ID: 30722017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colistin pharmacokinetics: the fog is lifting.
    Couet W; Grégoire N; Marchand S; Mimoz O
    Clin Microbiol Infect; 2012 Jan; 18(1):30-9. PubMed ID: 21988234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colistin loading dose: evaluation of the published pharmacokinetic and clinical data.
    Vardakas KZ; Rellos K; Triarides NA; Falagas ME
    Int J Antimicrob Agents; 2016 Nov; 48(5):475-484. PubMed ID: 27743779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pharmacokinetic/pharmacodynamic model developed for the effect of colistin on Pseudomonas aeruginosa in vitro with evaluation of population pharmacokinetic variability on simulated bacterial killing.
    Mohamed AF; Cars O; Friberg LE
    J Antimicrob Chemother; 2014 May; 69(5):1350-61. PubMed ID: 24474432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. To B or not to B, that is the question: is it time to replace colistin with polymyxin B?
    Kassamali Z; Danziger L
    Pharmacotherapy; 2015 Jan; 35(1):17-21. PubMed ID: 25346395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Shedding light on the use of colistin: still gaps to be filled].
    Luque S; Grau S; Berenguer N; Horcajada JP; Sorlí L; Montero MM; Salas E
    Enferm Infecc Microbiol Clin; 2011 Apr; 29(4):287-96. PubMed ID: 21440335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colistin: still a lifesaver for the 21st century?
    Karaiskos I; Souli M; Galani I; Giamarellou H
    Expert Opin Drug Metab Toxicol; 2017 Jan; 13(1):59-71. PubMed ID: 27573251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pharmacokinetic-pharmacodynamic (PKPD) model based on in vitro time-kill data predicts the in vivo PK/PD index of colistin.
    Khan DD; Friberg LE; Nielsen EI
    J Antimicrob Chemother; 2016 Jul; 71(7):1881-4. PubMed ID: 26983860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colistin: efficacy and safety in different populations.
    Shahbazi F; Dashti-Khavidaki S
    Expert Rev Clin Pharmacol; 2015; 8(4):423-48. PubMed ID: 26041134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of a dosage regimen of colistin by pharmacokinetic/pharmacodynamic integration and modeling for treatment of G.I.T. disease in pigs.
    Guyonnet J; Manco B; Baduel L; Kaltsatos V; Aliabadi MH; Lees P
    Res Vet Sci; 2010 Apr; 88(2):307-14. PubMed ID: 19945722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Updated US and European Dose Recommendations for Intravenous Colistin: How Do They Perform?
    Nation RL; Garonzik SM; Li J; Thamlikitkul V; Giamarellos-Bourboulis EJ; Paterson DL; Turnidge JD; Forrest A; Silveira FP
    Clin Infect Dis; 2016 Mar; 62(5):552-558. PubMed ID: 26607424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colistin Population Pharmacokinetics after Application of a Loading Dose of 9 MU Colistin Methanesulfonate in Critically Ill Patients.
    Karaiskos I; Friberg LE; Pontikis K; Ioannidis K; Tsagkari V; Galani L; Kostakou E; Baziaka F; Paskalis C; Koutsoukou A; Giamarellou H
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7240-8. PubMed ID: 26369974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Challenge for higher colistin dosage in critically ill patients receiving continuous venovenous haemodiafiltration.
    Karaiskos I; Friberg LE; Galani L; Ioannidis K; Katsouda E; Athanassa Z; Paskalis H; Giamarellou H
    Int J Antimicrob Agents; 2016 Sep; 48(3):337-41. PubMed ID: 27474468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimizing use of colistin and polymyxin B in the critically ill.
    Nation RL; Li J
    Semin Respir Crit Care Med; 2007 Dec; 28(6):604-14. PubMed ID: 18095224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single- and multiple-dose pharmacokinetics and total removal of colistin in a patient with acute kidney injury undergoing extended daily dialysis.
    Strunk AK; Schmidt JJ; Baroke E; Bode-Böger SM; Martens-Lobenhoffer J; Welte T; Kielstein JT
    J Antimicrob Chemother; 2014 Jul; 69(7):2008-10. PubMed ID: 24651826
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical considerations for optimal use of the polymyxins: A focus on agent selection and dosing.
    Pogue JM; Ortwine JK; Kaye KS
    Clin Microbiol Infect; 2017 Apr; 23(4):229-233. PubMed ID: 28238870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.